论文部分内容阅读
随着现代医学、药学、免疫学、分子生物学等学科的迅速发展,肿瘤的治疗手段也在不断地完善。目前,除手术、放疗、化疗的综合应用外,在癌症治疗中,被称为第四种治疗模式的生物反应调节剂的应用正崭露头角,引起医学界的普遍关注。 众所周知,肿瘤的转移与复发是导致肿瘤患者死亡的根本原因。由于患者自身免疫功能低下,而手术、放疗及化疗在一定程度上抑制了机体的免疫力,使肿瘤更易于转移复发。生物反应调节剂则通过调节机体生物反应,增强细胞对机体抗癌机制的敏感性,或通过增强机
With the rapid development of modern medicine, pharmacy, immunology, molecular biology and other disciplines, the treatment of cancer is also constantly improving. At present, in addition to the comprehensive application of surgery, radiotherapy, and chemotherapy, the application of a biological response modifier known as the fourth therapeutic mode is emerging in the treatment of cancer, causing widespread concern in the medical community. It is well known that the metastasis and recurrence of tumors are the root cause of death of cancer patients. Because the patient’s own immune function is low, surgery, radiotherapy and chemotherapy to some extent inhibited the body’s immunity, making the tumor easier to metastasize and relapse. Biological response modifiers increase the sensitivity of cells to the body’s anti-cancer mechanisms by regulating the body’s biological response, or through enhancement mechanisms.